Tradestie Institutional Equity Comparison Engine
OGEN vs PTN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PTN Overall Edge
PTN Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palatin Technologies, Inc. (PTN) driven by superior Valuation, Momentum & Technical while OGEN counters with relative strength in Growth & Margin. Fundamentally, OGEN trades at N/M Forward P/E with 0.0% operating margin (-91.3% YoY revenue) versus PTN at 42.9x Forward P/E and -65.7% operating margin (-80.1% YoY). In options structure, OGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PTN
OGEN N/M vs PTN 42.9x Fwd P/E
Growth & Margin Winner
OGEN
Op Margin 0.0% vs -65.7% ยท YoY -91.3% vs -80.1%
Momentum & Technical Winner
PTN
1Y -82.6% vs -43.3% ยท 52W Pos 3% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OGEN
NYSE American
Oragenics Inc.
Pharmaceutical Preparations
$0.20
-1.49% 1D
Market Cap
$906,903
1M Return
-54.47%
1Y Return
-82.63%
Forward P/E
N/M
Unified AI Score
38.8 / 100
SELL
Tech 25.0
Fund 46.0
Flow 50.0
Mom 75.0
PTN
US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap
$11.1M
1M Return
+1.74%
1Y Return
-43.29%
Forward P/E
42.9x
Unified AI Score
31.5 / 100
SELL
Tech 15.0
Fund 30.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OGEN -82.63%
PTN -43.29%
Spread: +39.34 pp (PTN Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | OGEN Revenue | PTN Revenue | OGEN Op. Margin | PTN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $70M | N/A | 38.6% | PTN |
| FY2019 | N/A | $60M | N/A | 59.3% | PTN |
| FY2020 | N/A | $0M | N/A | -20007.6% | PTN |
| FY2021 | $0M | N/A | -18130.3% | N/A | OGEN |
| FY2022 | $0M | $0M | -10964.6% | -2491.6% | PTN |
| FY2023 | $0M | $0M | -55519.9% | -668.7% | PTN |
| FY2024 | N/A | $0M | N/A | -501.0% | PTN |
| FY2026 | N/A | $10M | N/A | -65.7% | PTN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OGEN | PTN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $906,903 | $11.1M | Larger Scale | PTN |
| Trailing P/E Ratio Valuation | N/M | 42.9x | Lower Multiple | PTN |
| Forward P/E Ratio Valuation | N/M | 42.9x | Lower Multiple | PTN |
| Revenue Growth (YoY) Growth | -91.3% | -80.1% | Higher Growth | PTN |
| Operating Margin (TTM) Profitability | 0.0% | -65.7% | Higher Margin | OGEN |
| Net Profit Margin Profitability | 0.0% | -63.5% | Higher Margin | OGEN |
| Return on Equity (ROE) Capital Efficiency | -1307.1% | -877.5% | Higher ROE | PTN |
| 52-Week Range Position Momentum | 3% ($0โ$1) | 6% ($5โ$31) | Stronger Trend | PTN |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 153% Vol | 0.87ฮฒ ยท 106% Vol | Lower Realized Risk | PTN |
| Unified Institutional Score Composite Signal | 38.8 / 100 (SELL) | 31.5 / 100 (SELL) | Higher Composite | OGEN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OGEN vs PTN Buy Guide
OGEN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PTN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OGEN nor PTN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.